Diaclone Recombinant Antibodies
Over the years, we have invested in recombinant antibody technologies to complete our range of monoclonal antibodies. Alongside our monoclonal antibody development platform by conventional hybridoma technology, Diaclone is now able to develop recombinant antibodies by optimized Phage Display technology.
A good example is our B-B49 clone (anti-IL-8).
Recombinant antibodies are developed in our laboratories for a wide range of applications (Flow Cytometry, Immunohistochemistry, Western Blot, Immunoprecipitation, ELISA, ELISpot and Biological assays …)
Standard sizes and Bulk formats available.
|
Description |
Target species |
Clone |
Synonym |
Read more |
|---|---|---|---|---|
|
Anti-Human CD141 Azide Free |
Human |
B-S24 |
Thrombomodulin |
|
|
Anti-Human CD141 Detection Antibody |
Human |
B-S24 |
Thrombomodulin |
|
|
Anti-Human IL-1β Azide Free |
Human |
B-A15 |
IL-1b, IL-1beta |
|
|
Anti-Human IL-1β PE Conjugated |
Human |
B-A15 |
IL-1b, IL-1beta |
|
|
Anti-Human IL-23 Azide Free |
Human |
B-F43 |
||
|
Anti-Human IL-23 Detection Antibody |
Human |
B-F43 |
||
|
Anti-Human IL-8 Azide Free |
Human |
B-B49 |
CXCL8 |
|
|
Anti-SARS-CoV-2 Nucleoprotein Azide Free |
SARS-CoV-2 |
CR3018 |
Nucleoprotein, SARS-CoV nucleoprotein, Nucleocapsid protein |
|
|
Anti-SARS-CoV-2 Spike S1 Protein Azide Free |
SARS-CoV-2 |
CR3022-IgG |
Receptor binding domain Spike protein, RBD spike protein |
|
|
Anti-SARS-CoV-2 Spike S1 Protein Azide Free (IgA) |
SARS-CoV-2 |
CR3022-IgA |
Receptor binding domain Spike protein, RBD spike protein |
|
| Anti-Human BCMA Azide Free | Human | B-B54 |
CD269 TNFRSF17 B cell maturation antigen |
Detail |
| Anti-Human BCMA Unconjugated | Human | B-B54 |
CD269 TNFRSF17 B cell maturation antigen |
Detail |